日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A Latent Autoantibody Axis Associated with Vascular Vulnerability in Ischemic Stroke: Integrated Statistical and Machine-Learning Analysis

缺血性卒中血管脆弱性相关的潜在自身抗体轴:综合统计和机器学习分析

Sugiyama, Tomohiro; Yoshida, Yoichi; Hiwasa, Takaki; Kubota, Masaaki; Mine, Seiichiro; Higuchi, Yoshinori

Increased autoantibodies against incretin indicate poor prognosis in patients with diabetes

糖尿病患者体内抗肠促胰岛素自身抗体水平升高预示着预后不良。

Takemoto, Minoru; Zhang, Bo-Shi; Hayashi, Aiko; Yamagata, Hiroki; Yoshida, Yoich; Koshizaka, Masaya; Onishi, Shunichiro; Yamaga, Masaya; Yoshida, Tomohiko; Hashimoto, Takahide; Ohtake, Naoki; Ishikawa, Takahiro; Takizawa, Hirotaka; Hiwasa, Takaki

Application of serum anti-ENO1 and anti-SSNA1 antibody biomarkers in predicting the prognosis of gastric cancer.

血清抗ENO1和抗SSNA1抗体生物标志物在预测胃癌预后中的应用

Yajima Satoshi, Ito Masaaki, Suzuki Takashi, Oshima Yoko, Sumazaki Makoto, Shiratori Fumiaki, Takizawa Hirotaka, Li Shu-Yang, Zhang Bo-Shi, Yoshida Yoichi, Matsutani Tomoo, Hiwasa Takaki, Shimada Hideaki

Atherosclerosis-related biomarker PABPC1 predicts pan-cancer events

动脉粥样硬化相关生物标志物PABPC1可预测泛癌事件

Lin, Miao; Hu, Liubing; Shen, Si; Liu, Jiyue; Liu, Yanyan; Xu, Yixian; Chen, Honglin; Sugimoto, Kazuo; Li, Jianshuang; Kamitsukasa, Ikuo; Hiwasa, Takaki; Wang, Hao; Xu, Anding

Association of high proprotein convertase subtilisin/kexin type 9 antibody level with poor prognosis in patients with diabetes: a prospective study

高蛋白转化酶枯草杆菌蛋白酶/kexin 9型抗体水平与糖尿病患者预后不良的相关性:一项前瞻性研究

Yamagata, Hiroki; Hayashi, Aiko; Yoshida, Yoich; Koshizaka, Masaya; Onishi, Shunichiro; Yoshida, Tomohiko; Hiwasa, Takaki; Takemoto, Minoru

Serum anti-PCK1 antibody levels are a prognostic factor for patients with diabetes mellitus

血清抗PCK1抗体水平是糖尿病患者的预后因素

Namiki, Toshiki; Takemoto, Minoru; Hayashi, Aiko; Yamagata, Hiroki; Ishikawa, Takahiro; Yokote, Koutaro; Li, Shu-Yang; Kubota, Masaaki; Zhang, Bo-Shi; Yoshida, Yoichi; Matsutani, Tomoo; Mine, Seiichiro; Machida, Toshio; Kobayashi, Yoshio; Terada, Jiro; Naito, Akira; Tatsumi, Koichiro; Takizawa, Hirotaka; Nakamura, Rika; Kuroda, Hideyuki; Iwadate, Yasuo; Hiwasa, Takaki

GADD34 activates p53 and may have utility as a marker of atherosclerosis

GADD34激活p53,可能作为动脉粥样硬化的标志物。

Tomiyoshi, Go; Nakamura, Rika; Shinmen, Natsuko; Yoshida, Yoichi; Mine, Seiichiro; Machida, Toshio; Iwase, Katsuro; Iwadate, Yasuo; Hiwasa, Takaki; Kuroda, Hideyuki

Combinational antibody detection approach increases the clinical validity of colorectal cancer screening

联合抗体检测方法提高了结直肠癌筛查的临床有效性

Kobayashi, Sohei; Hiwasa, Takaki; Kitamura, Kouichi; Kano, Masayuki; Hoshino, Tyuji; Hirano, Sho; Hashimoto, Mayuko; Seimiya, Masanori; Shimada, Hideaki; Nomura, Fumio; Matsubara, Hisahiro; Matsushita, Kazuyuki

Prognostic and diagnostic significance of preoperative Jumonji domain‑containing 6 antibodies in colorectal cancer

术前Jumonji结构域6抗体在结直肠癌中的预后和诊断意义

Yoshida, Kimihiko; Hiwasa, Takaki; Ito, Masaaki; Ushigome, Mitsunori; Takizawa, Hirotaka; Li, Shu-Yang; Zhang, Bo-Shi; Iwadate, Yasuo; Funahashi, Kimihiko; Shimada, Hideaki

The combination of positive anti‑WDR1 antibodies with negative anti‑CFL1 antibodies in serum is a poor prognostic factor for patients with esophageal carcinoma

血清中抗WDR1抗体阳性而抗CFL1抗体阴性的组合是食管癌患者预后不良的因素。

Ito, Masaaki; Yajima, Satoshi; Suzuki, Takashi; Oshima, Yoko; Nanami, Tatsuki; Sumazaki, Makoto; Shiratori, Fumiaki; Wang, Hao; Hu, Liubing; Takizawa, Hirotaka; Li, Shu-Yang; Iwadate, Yasuo; Hiwasa, Takaki; Shimada, Hideaki